Variant report
Variant | esv3356696 |
---|---|
Chromosome Location | chr8:20953522-20954770 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144499628 | chr8:20953526-20953527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570207359 | chr8:20953535-20953536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537611399 | chr8:20953561-20953562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113549954 | chr8:20953615-20953616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148389999 | chr8:20953628-20953629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541448064 | chr8:20953705-20953706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73621569 | chr8:20953776-20953777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182372231 | chr8:20953808-20953809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533335904 | chr8:20953854-20953855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141352937 | chr8:20953870-20953871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59034239 | chr8:20953872-20953873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28384250 | chr8:20953873-20953874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369273148 | chr8:20953908-20953909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187958778 | chr8:20953951-20953952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112435802 | chr8:20953960-20953961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74818347 | chr8:20954054-20954055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549306470 | chr8:20954060-20954061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531424785 | chr8:20954071-20954072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200718049 | chr8:20954081-20954082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201763555 | chr8:20954084-20954085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543181007 | chr8:20954086-20954087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376712358 | chr8:20954087-20954088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs28722644 | chr8:20954088-20954089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71524492 | chr8:20954090-20954091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371425950 | chr8:20954092-20954093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113274067 | chr8:20954116-20954117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs367976115 | chr8:20954134-20954135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372528776 | chr8:20954176-20954177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529303449 | chr8:20954177-20954178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185097448 | chr8:20954179-20954180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547523631 | chr8:20954191-20954192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566058313 | chr8:20954221-20954222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75596580 | chr8:20954275-20954276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552069775 | chr8:20954316-20954317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570328055 | chr8:20954361-20954362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377043819 | chr8:20954388-20954389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190736656 | chr8:20954448-20954449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192414140 | chr8:20954461-20954462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs151299293 | chr8:20954486-20954487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553516553 | chr8:20954507-20954508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571991094 | chr8:20954510-20954511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545447375 | chr8:20954514-20954515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140572884 | chr8:20954527-20954528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575884961 | chr8:20954535-20954536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111342550 | chr8:20954536-20954537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs118046016 | chr8:20954537-20954538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561534616 | chr8:20954574-20954575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544400044 | chr8:20954608-20954609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541490643 | chr8:20954613-20954614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117778960 | chr8:20954615-20954616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20949000-20958200 | Weak transcription | Psoas Muscle | Psoas |
2 | chr8:20949800-20956400 | Weak transcription | Fetal Brain Male | brain |
3 | chr8:20952200-20953800 | Enhancers | Spleen | Spleen |
4 | chr8:20952200-20954400 | Enhancers | Brain Germinal Matrix | brain |
5 | chr8:20952400-20956400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
6 | chr8:20952600-20953600 | Enhancers | Adipose Nuclei | Adipose |
7 | chr8:20952800-20953800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
8 | chr8:20953000-20953800 | Enhancers | Left Ventricle | heart |
9 | chr8:20953200-20953800 | Enhancers | Lung | lung |
10 | chr8:20953600-20958200 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr8:20953800-20956600 | Weak transcription | Lung | lung |
12 | chr8:20953800-20956800 | Weak transcription | Left Ventricle | heart |
13 | chr8:20954400-20956600 | Weak transcription | Brain Germinal Matrix | brain |